Organo-ID
Business Services · Turkey · 1-10 Employees
View Company Info for Free
Overview
Headquarters
60/2 Mithatpasa St No, Balcova, Izmir, 3...Phone Number
+90 5324474637Website
www.organo-id.comRevenue
<$5 MillionIndustry
About Organo-ID
Is Organo-ID your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Organo-ID is spiking on competitors!
Click to see if Organo-ID had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Organo-ID has new funding data
Congratulate Masked Content for being promoted to Masked Content at Organo-ID
Product Launch: Get notified when Organo-ID launches new products
Website visits: Recent activity has been detected on your website
Check if Organo-ID has recently received funding, and reach out quickly before it becomes old news!
Organo-ID, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Organo-ID recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Organo-ID is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Organo-ID is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Organo-ID.
Organo-ID Tech Stack
A closer look at the technologies used by Organo-ID
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Organo-ID
Organo-ID specializes in generating pre-clinical in vitro disease models using organoid technology, focusing on human cancer and liver pathologies. The company has developed methods for creating 3D functional liver organoids and patient-derived cancer organoids to evaluate drug responses for precision cancer therapy. They are involved in a TUBITAK... Read More